share_log

歐康維視生物-B:自願性公告 OT-702 III期臨床試驗於中國完成

OCUMENSION-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA

Hong Kong Stock Exchange ·  Apr 8 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more